Epicrispr Biotechnologies vs Tome Biosciences
Epicrispr Biotechnologies
The future of genetic medicine is epic
48 employees · est. 2018 · South San Francisco, United...
Tome Biosciences
The final chapter in genomic medicine
142 employees · est. 2021 · Watertown, United States
Epicrispr Biotechnologies is the older company (2018 vs 2021); Tome Biosciences is the larger of the two.
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Epicrispr Biotechnologies | Tome Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2018 older | 2021 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Watertown, United States |
| Employees | ||
| Employees | 48 | 142 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series B | Series A |
| Total Funding | ||
| Total Funding | $123.00M | $213.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 1 |
| Services | ||
| Services | Development of therapies to control gene expression, Utilization of epigenomic modulators, Creating customized treatments for specific diseases | facilitating domain purchases, providing domain insights, daily domain data updates, searchable domain database, SEO score analysis, third-party registrar connection |
| Target Customers | ||
| Target Customers | Patients with complex diseases, Caregivers, Healthcare Providers, Biotech Researchers | digital marketers, SEO specialists, domain investors, startups, brand managers, web developers |
| Taxonomy | ||
| Taxonomy | Genetic MedicineGene Expression ModulationCasMINI TechnologyIn Vivo TherapiesUltracompact TherapiesCRISPR/Cas Proteins +6 | Genomic MedicineProgrammable Genomic IntegrationGene TherapiesIntegrative Gene TherapiesCRISPR TechnologyGene Insertion +4 |
| Website | ||
| Website | epicrispr.com | tome.bio |
About Epicrispr Biotechnologies
Epicrispr Biotechnologies, founded in 2018, stands at the forefront of the biotechnology sector. With a vision aptly captured in its slogan, "The future of genetic medicine is epic," the company is pioneering ultracompact therapies that leverage the smallest known Cas protein, CasMINI, to modulate g...
About Tome Biosciences
Tome Biosciences, founded in 2021 and headquartered in the United States, is pioneering advancements in the Biotechnology sector. Under its slogan, "The final chapter in genomic medicine," the company leverages innovative programmable genomic integration (PGI) technology that facilitates the precise...
Also comparing in this category
We will tell you when either one moves
BounceWatch watches Epicrispr Biotechnologies and Tome Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.
Get notified when Epicrispr Biotechnologies or Tome Biosciences moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Frequently Asked Questions
Compare Epicrispr Biotechnologies with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Epicrispr Biotechnologies on 15 Jun 2026, and Tome Biosciences on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
